Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Results 1-3 of 3 for drugs segment:8801995

Written Answers — Department of Health: Healthcare Policy (17 Jan 2024)

Fergus O'Dowd: 1580. To ask the Minister for Health if he expects ozempic to be added to the GMS list for weight loss; the reason the drug is not available under the drug payments, considering the considerable impact it is having on weight and the associated positive effect it is having on health, thus reducing the long term requirement for other services linked to obesity and weight problems; and if he...

Written Answers — Department of Health: Healthcare Policy (17 Jan 2024)

Stephen Donnelly: I propose to take Questions Nos. 1580 and 1624 together. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013. Reimbursement is for licensed indications which have been granted market authorisation...

Written Answers — Department of Health: Healthcare Policy (17 Jan 2024)

Stephen Donnelly: ...extremely low in the adult population across the EU. Data on adolescent use of nicotine pouches in Ireland will be collected as part of the European School Survey Project on Alcohol and Other Drugs (ESPAD) in 2024. There is very little independent evidence available regarding any health harms from nicotine pouches, though they contain nicotine which is an addictive substance. My Department...

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person